N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine

C67H83N15O4S — CID 158135535

IUPACN-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine
SMILESCc1cccc([C@@H](C)Nc2nnc(C)c3cnc(N4CCS(=O)(=O)CC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(OC4CN(C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(O[C@H]4CCN(C)C4)cc23)c1C
InChIInChI=1S/C23H29N5O.C22H27N5O2S.C22H27N5O/c1-14-7-6-8-19(15(14)2)16(3)25-23-20-11-22(29-18-9-10-28(5)13-18)24-12-21(20)17(4)26-27-23;1-14-6-5-7-18(15(14)2)16(3)24-22-19-12-21(23-13-20(19)17(4)25-26-22)27-8-10-30(28,29)11-9-27;1-13-7-6-8-18(14(13)2)15(3)24-22-19-9-21(28-17-11-27(5)12-17)23-10-20(19)16(4)25-26-22/h6-8,11-12,16,18H,9-10,13H2,1-5H3,(H,25,27);5-7,12-13,16H,8-11H2,1-4H3,(H,24,26);6-10,15,17H,11-12H2,1-5H3,(H,24,26)/t16-,18+;16-;15-/m111/s1
InChIKeyFTHLAYALWKQGCE-MOPFLHEYSA-N
MW1194.57 g/mol
LogP11.38
Rot. Bonds14

About N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine

N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine (PubChem CID 158135535) has the molecular formula C67H83N15O4S and a molecular weight of 1194.57 g/mol. Its IUPAC name is N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine.

Molecular Properties

Compound NameN-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine
PubChem CID158135535
Molecular FormulaC67H83N15O4S
Molecular Weight1194.57 g/mol
Exact Mass1193.65
IUPAC NameN-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine
SMILESCc1cccc([C@@H](C)Nc2nnc(C)c3cnc(N4CCS(=O)(=O)CC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(OC4CN(C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(O[C@H]4CCN(C)C4)cc23)c1C
InChIInChI=1S/C23H29N5O.C22H27N5O2S.C22H27N5O/c1-14-7-6-8-19(15(14)2)16(3)25-23-20-11-22(29-18-9-10-28(5)13-18)24-12-21(20)17(4)26-27-23;1-14-6-5-7-18(15(14)2)16(3)24-22-19-12-21(23-13-20(19)17(4)25-26-22)27-8-10-30(28,29)11-9-27;1-13-7-6-8-18(14(13)2)15(3)24-22-19-9-21(28-17-11-27(5)12-17)23-10-20(19)16(4)25-26-22/h6-8,11-12,16,18H,9-10,13H2,1-5H3,(H,25,27);5-7,12-13,16H,8-11H2,1-4H3,(H,24,26);6-10,15,17H,11-12H2,1-5H3,(H,24,26)/t16-,18+;16-;15-/m111/s1
InChIKeyFTHLAYALWKQGCE-MOPFLHEYSA-N
XLogP11.38
TPSA214.42 Ų
H-Bond Donors3
H-Bond Acceptors19
Rotatable Bonds14
Heavy Atoms87
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001194.57
LogP ≤ 511.38
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1019

Analyze N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine?
The IUPAC name of N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine (CID 158135535) is N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine.
What is the SMILES notation for N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine?
The canonical SMILES for N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine is Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(N4CCS(=O)(=O)CC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(OC4CN(C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(O[C@H]4CCN(C)C4)cc23)c1C.
What is the InChIKey of N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine?
The InChIKey is FTHLAYALWKQGCE-MOPFLHEYSA-N. The full InChI is InChI=1S/C23H29N5O.C22H27N5O2S.C22H27N5O/c1-14-7-6-8-19(15(14)2)16(3)25-23-20-11-22(29-18-9-10-28(5)13-18)24-12-21(20)17(4)26-27-23;1-14-6-5-7-18(15(14)2)16(3)24-22-19-12-21(23-13-20(19)17(4)25-26-22)27-8-10-30(28,29)11-9-27;1-13-7-6-8-18(14(13)2)15(3)24-22-19-9-21(28-17-11-27(5)12-17)23-10-20(19)16(4)25-26-22/h6-8,11-12,16,18H,9-10,13H2,1-5H3,(H,25,27);5-7,12-13,16H,8-11H2,1-4H3,(H,24,26);6-10,15,17H,11-12H2,1-5H3,(H,24,26)/t16-,18+;16-;15-/m111/s1.
What are the key properties of N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine?
N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine has a molecular weight of 1194.57 g/mol, XLogP of 11.38, 14 rotatable bonds, 3 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-7-(1,1-dioxo-1,4-thiazinan-4-yl)-4-methylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(1-methylazetidin-3-yl)oxypyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-1-methylpyrrolidin-3-yl]oxypyrido[3,4-d]pyridazin-1-amine is sourced from PubChem (CID 158135535), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).